Alizé Pharma III presents preclinical results in osteoporosis

Antagene_actu
Antagene joints Cerba Healthcare
30 September 2016
Ispogen_IO
IPSOGEN (QIAGEN)
7 September 2016

Alizé Pharma III presents preclinical results in osteoporosis

AlizeePharma_3_actu

The HBD1 peptide exhibited strong bone anabolic potency in a model of post-menopausal osteoporosis